6th European CAR T-cell Meeting
Dates: February 15-17, 2024
Location: Valencia, Spain
Format: Hybrid
Chairs: Michael Hudecek & Anna Sureda
Registration is closed. Those already registratered can view on-demand content via the platform until March 17.
The European Hematology Association (EHA) and the EBMT are delighted to invite you to participate in the 6th edition of the jointly organised European CAR T-cell Meeting, taking place in Valencia (Spain) from February 15th to 17th, 2024, as a hybrid meeting. This extraordinary event stands as the biggest meeting of its kind in all of Europe, and we can’t wait for you to be a part of it.
Prepare to be captivated as we bring together the finest specialists and keynotes from around the world. The chance to engage in discussions with these distinguished professionals, including haematologists, oncologists, physicians, nurses, data managers, supply chain managers, and patient organisation representatives, is not something you want to miss.
Our carefully crafted programme covers a wide range of topics, including deep science, translational research, clinical advancements, and commercial development in the field of CAR T. This meeting will provide you with the latest insights in CAR T and reported clinical data, making it an invaluable opportunity to stay at the forefront of this rapidly evolving field. We genuinely believe that this event presents an amazing opportunity for you to expand your knowledge, network with industry leaders, and contribute to the advancement of CAR T.
We look forward to welcoming you in Valencia!
Yours sincerely,
Professor A Sureda Professor M Hudecek
Meeting Chair, EBMT Meeting Chair, EHA
Format
This is a Hybrid meeting, which can be attended in-person or virtually. The emphasis lies on the in-person participation in the program, but most sessions will be livestreamed via a virtual platform for those who can only follow the program remotely.
Target audience
The target audience is hematologists, oncologists, physicians, nurses, data managers, supply chain managers and patient organization representatives.
Program
The program will cover various CAR T-cell related topics and will include key note lectures, interactive debate sessions and more. The program outline is now available - please see the program page.
Abstract and Case submission
Abstract submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers.
Introduced in 2021, we are excited to announce the 4th Emerging Investigators EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2024. Submissions will be reviewed by the Scientific Program Committee. Three winners will be selected and each receive €10.000 and the opportunity to present their abstract in one of the Best Abstracts Sessions.
Abstract submission is now closed. For physician abstracts see this page, for nurse abstracts see here.
Registration
Registration is closed. See the registration & accommodation page for more information.
Scientific Program Committee
The meeting is led by A Sureda and M Hudecek, in close collaboration with the Scientific Program Committee (SPC). Together they have created the program and helped select speakers. The members are:
|
|
Key dates
Venue
Palacio de Congresos / Valencia Conference Centre
Avda. Cortes Valencianas, nº 60
46015 València
Sponsorship
This meeting is supported by:
Supreme Partners:
 |
 |
 |
Meeting Partners:
Exhibitors:
 |
 |
 |
 |
 |
There are various opportunities to support this educational course. For more information, please send an email to sponsorship@ehaweb.org or fundraising@ebmt.org to indicate your interest.
EBAH CME accreditation
This meeting is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with the up-to-date views on clinical policy will enable you to raise your professional level, ultimately resulting in the best treatment for your patients.
Back